Insider · CIK 0001913199
Stan Smith
Files at MAIA (MAIA Biotechnology, Inc.). First filing Nov 4, 2024, latest Jun 2, 2026.
In brief
Stan Smith files SEC Form 4 as director at MAIA (MAIA Biotechnology, Inc.). Since Nov 4, 2024, Stan Smith has reported 11 open-market buys worth $710k and 0 open-market sells worth $0, the latest filed on Jun 2, 2026.
After Stan Smith's past buys, the stock trailed the S&P 500 by a median 15.7% over six months (n = 10), and 10% of those buys were ahead of the index at six months. InsiderTell labels that a negative record.
The newest scored trade: bought $100k of MAIA on Jun 1, 2026, filed Jun 2, 2026, scored 46 (moderate). In the last 12 months: 6 buys worth $237k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MAIA: MAIA Biotechnology, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 46Moderate | MAIA Biotechnology, Inc. | $100k 75,000 shares | +5% | +49% from low-56% from high | |
| 10Weak | MAIAbuy MAIA Biotechnology, Inc. | $9,959 2,700 shares | +0% | - | |
| 51Moderate | MAIA Biotechnology, Inc. | $70k 57,189 shares | +4% | +53% from low-46% from high | |
| 51Moderate | MAIA Biotechnology, Inc. | $16k 13,740 shares | - | +38% from low-52% from high | |
| 43Moderate | MAIA Biotechnology, Inc. | $16k 15,000 shares | +1% | +22% from low-57% from high | |
| 43Moderate | MAIA Biotechnology, Inc. | $25k 25,000 shares | +2% | +14% from low-60% from high | |
| 23Weak | MAIAbuy MAIA Biotechnology, Inc. | $25k 19,230 shares | +1% | +15% from low-50% from high | |
| 35Weak | MAIAbuy MAIA Biotechnology, Inc. | $50k 33,333 shares | +3% | +22% from low-47% from high | |
| 44Moderate | MAIA Biotechnology, Inc. | $100k 66,666 shares | +6% | +36% from low-41% from high | |
| 34Weak | MAIA Biotechnology, Inc. | $47k 25,000 shares | +2% | - | |
| 46Moderate | MAIA Biotechnology, Inc. | $251k 100,000 shares | +12% | - |
Transactions
Every row this insider has filed, 28 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | MAIA MAIA Biotechnology, Inc. | AGrant or award Stock Optionsderivativeindirect: See footnote | +38,871 | $0.00 | $0 | 38,871 | 11 d ago |
| Jun 30, 2026 | MAIA MAIA Biotechnology, Inc. | AGrant or award Stock Optionsderivativeindirect: See footnote | +32,003 | $0.00 | $0 | 32,003 | Jul 2, 2026 |
| Jun 1, 2026 | MAIA MAIA Biotechnology, Inc. | POpen-market purchase Common Stockindirect: See Footnote | +75,000 | $1.34 | $100k | 1,519,178 | Jun 2, 2026 |
| Mar 31, 2026 | MAIA MAIA Biotechnology, Inc. | AGrant or award Stock Optionsderivativeindirect: See footnote | +33,099 | $0.00 | $0 | 33,099 | Apr 2, 2026 |
| Sep 19, 2022 | MAIA MAIA Biotechnology, Inc. | POpen-market purchase Common Stockindirect: See Footnote | +2,700 | $3.69 | $9,959 | 1,424,178 | Jan 12, 2026 |
| May 1, 2024 | MAIA MAIA Biotechnology, Inc. | GGift Common Stockindirect: See Footnote | +20,000 | $0.00 | $0 | 1,444,178 | Jan 12, 2026 |
| Dec 31, 2025 | MAIA MAIA Biotechnology, Inc. | AGrant or award Optionsderivativeindirect: See footnote | +29,216 | $0.00 | $0 | 29,216 | Jan 5, 2026 |
| Dec 22, 2025 | MAIA MAIA Biotechnology, Inc. | POpen-market purchase Common Stockindirect: See Footnote | +57,189 | $1.22 | $70k | 1,421,478 | Dec 23, 2025 |
| Dec 22, 2025 | MAIA MAIA Biotechnology, Inc. | POpen-market purchase Stock Optionsderivativeindirect: See footnote | +57,189 | $1.36 | $78k | 57,189 | Dec 23, 2025 |
| Dec 5, 2025 | MAIA MAIA Biotechnology, Inc. | POpen-market purchase Common Stockindirect: See footnote | +4,580 | $1.20 | $5,495 | 4,580 | Dec 9, 2025 |
| Dec 5, 2025 | MAIA MAIA Biotechnology, Inc. | POpen-market purchase Common Stockindirect: See footnote | +4,580 | $1.19 | $5,450 | 4,580 | Dec 9, 2025 |
| Dec 5, 2025 | MAIA MAIA Biotechnology, Inc. | POpen-market purchase Common Stockindirect: See footnote | +4,580 | $1.20 | $5,496 | 4,580 | Dec 9, 2025 |
| Nov 26, 2025 | MAIA MAIA Biotechnology, Inc. | POpen-market purchase Common Stockindirect: See Footnote | +15,000 | $1.04 | $16k | 1,364,289 | Dec 1, 2025 |
| Nov 24, 2025 | MAIA MAIA Biotechnology, Inc. | POpen-market purchase Common Stockindirect: See Footnote | +10,000 | $0.99 | $9,900 | 1,334,289 | Nov 26, 2025 |
| Nov 25, 2025 | MAIA MAIA Biotechnology, Inc. | POpen-market purchase Common Stockindirect: See Footnote | +15,000 | $0.98 | $15k | 1,349,289 | Nov 26, 2025 |
| Oct 2, 2025 | MAIA MAIA Biotechnology, Inc. | AGrant or award Stock Optionsderivativeindirect: See Footnote | +24,844 | $0.00 | $0 | 24,844 | Oct 6, 2025 |
| Oct 1, 2025 | MAIA MAIA Biotechnology, Inc. | POpen-market purchase Common Stockindirect: See Footnote | +19,230 | $1.30 | $25k | 1,324,289 | Oct 2, 2025 |
| Oct 1, 2025 | MAIA MAIA Biotechnology, Inc. | POpen-market purchase Warrantsderivativeindirect: See footnote | +19,230 | $1.57 | $30k | 19,230 | Oct 2, 2025 |
| Jun 30, 2025 | MAIA MAIA Biotechnology, Inc. | AGrant or award Stock Optionsderivativeindirect: See footnote | +24,747 | $0.00 | $0 | 24,747 | Jul 2, 2025 |
| Jun 3, 2025 | MAIA MAIA Biotechnology, Inc. | POpen-market purchase Common Stockindirect: See Footnote | +33,333 | $1.50 | $50k | 1,305,059 | Jun 5, 2025 |
| Jun 3, 2025 | MAIA MAIA Biotechnology, Inc. | POpen-market purchase Warrantsderivativeindirect: See Footnote | +33,333 | $1.71 | $57k | 33,333 | Jun 5, 2025 |
| May 8, 2025 | MAIA MAIA Biotechnology, Inc. | POpen-market purchase Common Stockindirect: See Footnote | +66,666 | $1.50 | $100k | 1,271,726 | May 12, 2025 |
| May 8, 2025 | MAIA MAIA Biotechnology, Inc. | POpen-market purchase Warrantsderivativeindirect: See Footnote | +66,666 | $2.05 | $137k | 66,666 | May 12, 2025 |
| Apr 4, 2025 | MAIA MAIA Biotechnology, Inc. | AGrant or award Stock Optionsderivativeindirect: See Footnote | +24,800 | $0.00 | $0 | 24,800 | Apr 8, 2025 |
| Dec 13, 2024 | MAIA MAIA Biotechnology, Inc. | POpen-market purchase Common Stockindirect: See Footnote | +25,000 | $1.87 | $47k | 1,130,060 | Dec 13, 2024 |
| Dec 13, 2024 | MAIA MAIA Biotechnology, Inc. | POpen-market purchase Warrantsderivativeindirect: See Footnote | +25,000 | $2.08 | $52k | 25,000 | Dec 13, 2024 |
| Nov 1, 2024 | MAIA MAIA Biotechnology, Inc. | POpen-market purchase Common Stockindirect: See Footnote | +100,000 | $2.51 | $251k | 957,568 | Nov 4, 2024 |
| Nov 1, 2024 | MAIA MAIA Biotechnology, Inc. | POpen-market purchase Warrantsderivativeindirect: See Footnote | +100,000 | $2.26 | $226k | 100,000 | Nov 4, 2024 |
Questions about Stan Smith
Answered from the filings on this page, as of the latest one.
Is Stan Smith buying or selling?
In the last 12 months Stan Smith reported 6 open-market buys worth $237k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $100k of MAIA on Jun 1, 2026. Grants, option exercises and tax withholding are not counted.
How did Stan Smith's past buys perform?
Measured from the first close after each filing, the stock trailed the S&P 500 by a median 15.7% over six months across 10 past buys, with 10% ahead of the index. Past results describe what happened; they do not predict the next trade.
Where does Stan Smith file Form 4?
Stan Smith has filed Form 4 at MAIA (MAIA Biotechnology, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.